Is BioCryst Pharmaceuticals, Inc. (BCRX) a Buy, Sell, or Hold?
NASDAQ : BCRX
BioCryst Pharmaceuticals, Inc. — Competitors
$9.795 USD
$0.46 (4.87%)
- Volume
- 1.27M
- Average Volume
- 4.95M
- Market Capitalization
- $2.49B
- P/E Ratio
- -5.67
- Dividend Yield
- 0.00%
- Price Target
- $17.00
- Year High
- $11.22
- Year Low
- $6.00
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $1.91
BCRX vs. The Competition
| Properties | BCRX | ARDX | MAZE | NTLA |
|---|---|---|---|---|
| Market Cap | $2.49B | $1.27B | $1.59B | $1.22B |
| Shares Outstanding | $254.16M | $247.03M | $55.35M | $112.21M |
| P/E Ratio | -5.67 | -21.87 | -10.42 | -3.06 |
| EPS | -1.89 | -0.24 | -2.27 | -3.33 |
| Day Low | 9.6 | 5.085 | 27.69 | 10.63 |
| Day High | 9.91 | 5.21 | 28.91 | 11.31 |
| Year Low | 6 | 4.075 | 12.81 | 7.95 |
| Year High | 11.22 | 8.4 | 53.65 | 28.25 |
| Average Price 50 | 9.2406 | 5.6616 | 27.0283 | 13.91 |
| Average Price 200 | 8.1766 | 6.02995 | 34.5816 | 13.40318 |
| Volume | 1.27M | 637.5K | 80660.89 | 1.13M |
| Average Volume | - | - | - | - |